AFM28
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AFM28, covering 2025-07-23 to 2025-07-23. Get the full timeline:
Most recent: Clinical Trial Update: First-in-Human Dose Escalation Study of AFM28 in Patients With Relapsed/Refractory Acute Myeloid Leukemia [Phase 1]